hg_67839.1

Basic information about the TSS

---

TSS ID: hg_67839.1 Species: human Chr: chr6		Start: 42929394 End: 42929411 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000372836.5 Distance: 69 GeneID: 10695 HGNC/MGI_ID: HGNC:11968 UniProt_ID: Q9BT09

Gene_name: canopy FGF signaling regulator 3 Gene_symbol: CNPY3 Gene_synonyms: CAG4A Gene_source: HGNC:11968

TATA-Box annotation

---

Distance to TSS:	-77
Nearest PromoterID:	NM_006586
Entrez ID:	10695
Nearest Unigene:	Hs.414099
Nearest Refseq:	NM_006586
Nearest Ensembl:	ENSG00000137161
Gene Name:	canopy FGF signaling regulator 3
Gene Alias:	CAG4A|EIEE60|ERDA5|PRAT4A|TNRC5
Gene Description:	canopy FGF signaling regulator 3
Gene Type:	protein-coding
CpG%:	0.085
GC%:	0.626866
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CNPY3 p2@CNPY3 p3@CNPY3 p4@CNPY3
Sample		p1@CNPY3	p2@CNPY3	p3@CNPY3	p4@CNPY3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.77	0.78	4.68	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	25.49	0.61	4.86	3.24
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	24.88	0.96	3.09	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.16	1.04	4.57	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.27	0.45	4.05	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.36	0.97	5.43	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.44	1.31	5.01	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.23	0.97	5.09	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.52	0.64	3.42	2.99
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.14	1.16	4.06	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.10	1.62	5.26	6.47
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	31.71	0.81	6.10	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.25	1.61	4.19	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.49	1.35	3.91	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.39	0.88	2.42	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.33	0.50	6.29	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.54	1.53	4.59	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	0.42	5.91	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	1.60	4.80	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.79	0.90	4.21	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.64	1.60	4.54	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.95	0.35	4.32	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.54	0.90	4.65	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.62	0.97	4.61	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.35	1.03	4.13	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	0.32	3.17	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	1.10	7.14	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.91	0.71	4.48	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.34	0.97	4.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.57	0.90	3.26	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.72	0.84	4.40	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.70	1.17	4.30	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.61	1.06	2.95	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.55	0.99	6.10	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.34	0.56	3.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.41	0.38	3.45	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.10	0.82	4.50	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.48	1.61	5.04	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.07	1.08	1.62	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.44	0.48	2.16	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.94	0.47	3.53	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.03	2.20	6.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.29	1.48	4.85	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.19	1.05	3.85	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.84	0.20	2.81	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.24	0.70	3.02	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.24	0.00	4.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.22	0.89	1.79	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	1.20	3.11	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.91	1.01	3.44	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.07	1.23	1.64	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.12	1.56	2.45	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.45	0.35	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	2.98	4.64	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	19.30	0.84	0.84	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	0.00	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.21	0.65	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.74	0.64	2.57	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.55	1.57	2.51	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	0.71	2.82	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	0.56	3.36	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	0.00	3.98	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	0.34	2.38	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.60	0.97	4.87	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.36	1.06	4.26	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.19	1.95	4.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.38	1.49	4.46	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.48	1.41	1.88	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.59	1.99	2.65	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.47	1.55	5.26	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.82	2.14	3.36	1.83
Adipocyte - breast, donor1	11376-118A8	18.85	2.53	2.38	0.48
Adipocyte - breast, donor2	11327-117E4	12.51	0.32	2.41	0.48
Adipocyte - omental, donor1	11473-119C6	16.79	2.80	3.94	0.25
Adipocyte - omental, donor2	11474-119C7	14.20	1.49	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	20.10	2.01	2.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.95	5.10	3.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	1.35	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.38	1.56	1.74	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	28.55	3.13	0.98	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	2.57	1.29	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	19.24	1.95	2.23	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	8.82	2.94	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	10.30	1.37	0.64	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	11.94	0.97	2.90	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	1.07	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	0.00	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.55	1.26	1.76	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	5.56	0.33	2.62	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	18.78	3.31	3.31	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	32.27	2.51	5.02	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	1.20	4.79	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	16.37	1.44	3.96	2.70
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	0.00	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.80	2.26	4.52	2.26
Anulus Pulposus Cell, donor1	11248-116E6	13.50	1.83	3.78	0.80
Anulus Pulposus Cell, donor2	11463-119B5	10.29	1.96	2.69	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	0.90	1.80	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.84	3.47	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.14	1.79	2.09	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	6.32	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	0.00	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	1.62	2.27	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.50	1.94	2.43	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	0.59	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.57	1.88	1.88	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	2.18	3.63	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.67	0.49	2.14	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.17	0.75	1.21	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	3.75	2.68	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.11	1.89	3.59	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	0.80	4.54	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.74	1.99	1.49	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	2.40	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.64	1.89	3.26	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.05	2.43	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.42	1.52	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	2.28	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.03	1.50	1.07	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.07	1.03	3.36	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	2.82	3.75	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.33	1.29	1.93	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	2.14	3.57	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	0.58	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.55	1.51	3.31	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	4.75	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.33	1.02	3.05	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	2.55	3.57	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	0.64	1.27	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	0.86	3.45	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.03	1.48	3.39	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	1.45	1.74	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	19.33	1.86	1.70	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.22	1.93	1.29	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	3.01	3.61	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.93	1.38	2.30	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.46	1.78	2.03	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.52	2.06	2.27	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.24	1.22	1.84	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	1.91	2.87	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.29	2.22	1.11	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	4.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	2.22	4.43	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.54	2.38	2.38	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	0.73	2.54	0.00
Astrocyte - cerebellum, donor1	11500-119F6	23.58	3.07	3.56	3.32
Astrocyte - cerebellum, donor2	11580-120F5	22.94	4.11	3.77	3.77
Astrocyte - cerebellum, donor3	11661-122F5	13.42	3.15	5.66	3.15
Astrocyte - cerebral cortex, donor1	11235-116D2	20.22	1.74	5.58	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	19.25	1.46	2.59	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	2.83	2.24	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	40.71	4.36	2.41	2.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.96	4.26	3.13	1.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	33.80	4.44	3.87	1.59
Basophils, donor1	12241-129G9	54.66	31.38	2.09	0.00
Basophils, donor2	12242-129H1	57.73	24.53	0.72	0.00
Basophils, donor3	12243-129H2	74.67	42.78	1.91	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	10.35	0.43	2.80	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	35.66	3.66	3.66	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	18.92	2.29	2.08	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	9.67	2.07	3.45	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	12.78	0.36	2.70	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.52	7.63	3.30	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	30.51	3.03	1.40	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	92.41	25.90	7.35	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	20.68	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	61.99	33.25	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	50.67	31.37	2.78	0.00
CD14+ Monocytes, donor3	11381-118B4	60.37	35.13	1.98	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	63.68	34.81	4.25	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.04	23.88	3.41	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	52.93	24.66	2.96	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	38.74	36.43	3.18	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	24.74	24.14	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	38.61	30.80	4.26	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.92	19.75	1.67	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	17.94	15.46	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.59	15.62	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	22.52	17.43	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.59	19.05	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.94	22.42	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.48	18.96	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	21.12	17.95	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	24.41	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.14	25.29	1.78	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.16	18.16	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.28	19.78	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	21.96	19.45	1.14	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.91	15.61	1.81	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	15.28	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.56	22.33	1.88	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	29.31	27.39	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.45	24.41	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.06	20.02	0.73	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	12.33	12.68	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	9.21	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.02	19.88	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.56	17.10	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.72	33.41	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	14.33	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.98	9.50	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.86	14.62	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	57.76	35.31	3.49	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	62.60	46.89	3.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	66.93	42.46	1.95	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	81.75	71.94	6.07	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	73.35	60.43	4.19	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	86.51	53.29	5.57	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	77.83	53.84	2.55	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	55.55	44.57	0.88	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	87.80	46.95	4.00	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	101.62	28.45	8.13	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	89.49	38.64	16.95	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	30.03	7.25	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	83.15	30.38	9.59	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	93.81	34.84	13.40	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	89.85	28.78	14.04	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	25.88	9.41	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	43.50	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	77.26	22.19	5.75	0.00
CD19+ B Cells, donor2	11624-122B4	66.01	22.49	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	62.60	11.61	8.58	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	16.97	0.81	1.62	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	15.98	0.80	1.60	2.00
CD34+ Progenitors, donor1	11545-120B6	32.13	14.06	2.01	3.01
CD34+ Progenitors, donor2	11625-122B5	29.21	10.11	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	98.82	24.05	10.90	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	83.20	21.20	8.34	4.51
CD4+ T Cells, donor1	11225-116C1	71.77	7.50	3.21	0.36
CD4+ T Cells, donor2	11306-117C1	53.28	3.06	3.06	0.00
CD4+ T Cells, donor3	11382-118B5	52.76	9.45	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.06	2.30	2.55	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.34	5.17	2.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.05	3.74	2.59	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	68.74	12.33	7.59	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	79.36	16.15	7.73	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	13.18	13.18	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.11	5.78	1.88	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.03	4.24	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.21	2.90	2.74	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	34.52	13.90	5.38	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	43.67	9.78	2.45	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.16	4.40	3.96	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.72	6.75	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.15	5.82	1.04	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	31.41	3.01	1.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	61.73	7.34	5.17	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.07	10.72	3.75	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	69.94	10.76	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.93	5.38	1.11	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.09	6.93	2.60	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	35.52	4.83	2.10	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	53.09	8.60	5.56	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	59.36	7.80	3.03	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	49.25	6.97	3.05	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	80.17	11.88	2.47	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	71.09	12.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	87.94	13.96	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	78.09	18.00	2.77	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	78.77	17.18	3.93	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	18.48	6.16	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	70.55	23.28	5.01	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	90.02	13.85	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	52.06	10.15	1.64	0.00
CD8+ T Cells, donor2	11307-117C2	47.30	4.88	2.63	0.75
CD8+ T Cells, donor3	11383-118B6	83.57	11.87	3.28	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.73	1.84	2.29	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.82	1.92	2.88	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.51	1.09	2.46	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.01	2.10	2.40	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.44	0.48	2.88	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.37	0.91	1.82	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.60	0.87	1.52	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.37	0.79	1.84	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.95	0.94	1.88	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.60	0.91	1.21	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.85	0.87	1.16	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.52	1.87	1.60	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.20	0.91	2.28	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	17.65	1.44	2.52	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.40	0.86	1.73	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.49	0.71	0.71	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.99	0.95	1.58	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.99	1.54	1.85	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	0.96	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.83	1.15	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.01	0.79	1.97	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	0.76	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	13.65	1.61	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	0.70	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	22.23	0.99	1.48	2.47
Cardiac Myocyte, donor3	11686-122I3	14.10	1.58	2.84	1.05
Chondrocyte - de diff, donor1	11261-116G1	14.56	3.12	3.47	0.69
Chondrocyte - de diff, donor2	11338-117F6	11.37	1.78	3.55	0.36
Chondrocyte - de diff, donor3	11410-118E6	15.70	1.59	1.82	0.34
Chondrocyte - re diff, donor2	11339-117F7	12.53	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	18.60	1.21	4.45	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	18.13	1.84	3.44	2.52
Ciliary Epithelial Cells, donor2	11323-117D9	12.61	1.28	1.50	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	16.90	2.04	4.16	2.30
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.01	8.25	7.52	1.38
Corneal Epithelial Cells, donor1	11526-119I5	18.88	1.76	2.85	1.76
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	13.55	2.05	1.79	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.85	8.09	3.47	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	25.55	9.46	2.84	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	10.35	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.33	7.67	2.38	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	266.82	80.29	11.96	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	311.42	77.69	12.40	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	292.79	68.24	15.49	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	12.17	4.17	3.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	2.35	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	14.42	2.83	2.55	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	4.72	3.15	0.39
Endothelial Cells - Artery, donor1	11264-116G4	13.96	2.33	1.75	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.29	2.35	2.82	0.24
Endothelial Cells - Artery, donor3	11413-118E9	12.80	2.80	2.45	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.41	5.76	2.66	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	19.17	5.17	2.43	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.99	4.51	4.51	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	5.05	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.29	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.08	4.96	3.69	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	10.00	3.60	4.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	1.57	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	18.14	4.85	2.86	2.48
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.99	5.43	2.17	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.20	3.66	2.32	0.49
Endothelial Cells - Vein, donor1	11267-116G7	10.24	3.41	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	13.97	2.79	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	18.84	4.40	3.30	1.57
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	103.97	123.77	13.20	3.30
Eosinophils, donor3	12246-129H5	117.71	99.87	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	16.86	1.47	0.98	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.78	2.46	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.03	1.53	1.86	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.80	1.30	1.30	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.10	2.18	2.30	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.10	1.50	5.05	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.35	3.06	1.37	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	3.16	10.01	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.27	2.99	2.66	1.66
Fibroblast - Cardiac, donor1	11268-116G8	15.88	0.91	4.08	0.91
Fibroblast - Cardiac, donor2	11345-117G4	9.85	0.76	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.51	2.68	3.47	1.42
Fibroblast - Cardiac, donor4	11452-119A3	13.03	2.42	2.12	0.91
Fibroblast - Cardiac, donor5	11456-119A7	11.68	2.03	2.03	1.02
Fibroblast - Cardiac, donor6	11460-119B2	13.64	1.67	1.52	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.06	2.41	2.95	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.92	1.29	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	1.46	1.46	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	11.53	1.38	6.69	3.23
Fibroblast - Conjunctival, donor3	11692-122I9	14.59	3.22	3.22	0.68
Fibroblast - Dermal, donor1	11269-116G9	6.34	0.70	1.41	0.23
Fibroblast - Dermal, donor2	11346-117G5	8.96	3.77	4.25	0.94
Fibroblast - Dermal, donor3	11418-118F5	10.28	1.09	1.57	0.36
Fibroblast - Dermal, donor4	11450-119A1	15.26	2.15	2.03	1.70
Fibroblast - Dermal, donor5	11454-119A5	13.08	2.62	2.44	1.40
Fibroblast - Dermal, donor6	11458-119A9	17.38	1.79	2.27	1.46
Fibroblast - Gingival, donor1	11237-116D4	9.79	1.67	2.50	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.20	2.36	0.52	0.79
Fibroblast - Gingival, donor2	11318-117D4	14.23	0.66	2.37	1.71
Fibroblast - Gingival, donor3	11394-118C8	8.12	0.77	2.32	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	3.12	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.28	2.47	1.41	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.84	2.49	1.40	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.14	2.84	1.76	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.47	3.53	2.47	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.48	1.17	2.05	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.82	1.64	0.95	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	12.29	1.21	1.65	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	9.68	1.76	3.08	0.44
Fibroblast - Lung, donor1	11270-116H1	9.52	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	17.52	2.11	2.53	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	4.17	0.83	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.87	1.12	1.96	1.12
Fibroblast - Mammary, donor1	11540-120B1	20.30	1.62	2.44	1.22
Fibroblast - Mammary, donor2	11620-122A9	39.94	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.13	2.33	2.13	2.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.80	1.37	3.03	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.02	0.61	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.88	2.67	1.53	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.36	3.24	1.62	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.16	2.20	2.32	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.13	2.98	3.32	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.43	1.42	2.44	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.71	2.67	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	3.16	3.16	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.86	2.78	2.98	3.37
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.52	1.07	2.66	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.95	1.18	1.97	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	26.17	1.81	5.42	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.55	2.05	3.67	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.14	2.28	3.04	1.77
Fibroblast - skin normal, donor1	11553-120C5	15.10	3.28	2.63	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.27	2.41	4.61	2.01
Fibroblast - skin normal, donor2	11561-120D4	17.08	3.21	2.11	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	11.79	1.81	4.23	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.59	1.49	2.73	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.70	1.54	2.56	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	28.57	4.93	3.61	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.62	3.41	1.60	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	17.21	2.19	2.87	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	20.86	2.51	2.20	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	3.49	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.14	1.56	1.21	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.52	1.56	1.30	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.35	0.51	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	25.26	5.36	3.06	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.92	3.83	7.66	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	40.22	3.71	8.27	7.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	31.16	4.96	4.69	4.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.03	2.28	2.28	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.27	3.76	5.75	5.35
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	35.95	2.64	5.29	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.77	3.59	1.96	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	2.65	9.29	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.84	3.39	4.95	3.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.03	4.06	3.57	1.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.95	2.95	2.69	2.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.65	2.35	4.09	2.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.22	3.18	3.88	3.05
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.45	1.83	2.85	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.50	2.97	4.11	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.42	2.74	3.74	2.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.55	2.62	2.84	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.18	3.25	3.55	2.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.50	3.50	3.34	4.13
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	26.81	2.01	2.46	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.83	4.03	2.42	3.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	28.33	3.90	2.71	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.08	5.32	3.10	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.04	4.68	2.91	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.03	2.56	3.59	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.32	3.54	3.43	3.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.87	3.91	2.33	1.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.97	1.84	4.29	3.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.64	3.30	3.30	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	28.02	4.15	4.04	1.96
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.02	4.67	1.67	3.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.47	3.97	5.73	3.75
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.04	2.71	4.55	2.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.31	3.73	3.08	2.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	21.49	4.17	5.77	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.28	4.07	3.13	2.75
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.36	3.16	0.95	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.81	2.43	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.79	3.55	2.93	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.42	5.49	3.73	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	3.37	2.52	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.55	2.22	1.67	1.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.19	2.14	1.60	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.39	3.37	1.22	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.96	2.72	1.68	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.50	3.52	1.90	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	26.18	2.58	4.06	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.69	2.41	3.51	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	0.99	5.95	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.29	2.11	3.30	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.58	2.82	2.42	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.57	3.56	5.59	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	27.07	2.39	7.17	4.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	26.35	4.93	5.55	5.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	33.96	2.45	3.68	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.63	3.13	4.69	3.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	44.36	3.96	5.09	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	33.67	1.84	2.77	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	4.95	2.47	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	54.15	4.64	3.87	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	3.21	8.02	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	66.08	6.96	6.96	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	45.89	4.23	5.21	3.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.77	3.71	2.88	4.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	6.66	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	44.46	2.24	3.64	4.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.14	3.60	1.96	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.94	5.87	4.19	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	45.17	3.50	3.82	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.76	2.72	3.06	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	4.18	6.26	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	1.72	4.01	6.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.52	2.37	5.92	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	3.39	3.39	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	40.59	2.90	4.97	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	46.49	3.91	3.22	5.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	5.27	15.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.60	4.23	3.84	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.29	3.26	5.22	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	31.44	3.34	4.68	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.52	3.85	6.55	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.07	3.77	8.56	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	24.06	4.25	8.97	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	30.17	3.62	4.83	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	34.08	4.58	5.60	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	37.49	1.60	5.58	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	2.96	5.43	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	3.54	3.54	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	2.33	5.25	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	27.65	3.95	9.22	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	25.43	0.00	5.09	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	2.98	2.98	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	1.94	4.85	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	23.70	3.33	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.07	0.63	1.27	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	0.84	2.09	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	36.32	3.13	2.55	2.90
Hep-2 cells mock treated, biol_rep2	11899-125E9	36.63	2.36	3.54	2.70
Hep-2 cells mock treated, biol_rep3	11900-125F1	33.44	1.14	3.87	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	37.06	3.39	2.73	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	39.11	4.51	1.29	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.71	1.72	3.01	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.62	2.74	3.24	3.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	31.91	2.40	2.74	2.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.31	1.28	1.60	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	9.51	1.68	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.13	3.90	3.46	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.04	5.29	4.23	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.97	2.18	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.36	0.87	1.92	3.15
Hepatocyte, donor1	11523-119I2	15.74	1.21	1.21	2.42
Hepatocyte, donor2	11603-120I1	17.24	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	29.45	2.45	0.61	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	55.48	7.18	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.44	2.10	4.02	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.72	0.82	4.53	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	0.00	3.18	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	4.15	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	5.01	12.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	2.56	0.00	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	0.00	6.50	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	5.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	3.63	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	1.32	1.32	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.16	0.00	3.15	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	3.09	4.64	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	0.65	1.94	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	0.00	6.44	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	4.07	3.26	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.25	0.84	5.04	3.36
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	1.61	4.82	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	0.00	3.69	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.99	0.47	1.42	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	0.91	7.26	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	2.15	7.53	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	0.00	0.00	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	0.00	6.38	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	1.82	5.47	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	2.14	5.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	6.64	3.32	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.67	1.54	2.78	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	5.27	7.02	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	6.29	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	3.48	2.78	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	3.24	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.87	3.49	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	0.00	2.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	2.13	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	4.16	6.93	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	14.73	3.68	9.20	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	2.11	4.23	2.11
Keratinocyte - epidermal, donor1	11272-116H3	8.32	0.82	0.73	0.73
Keratinocyte - epidermal, donor2	11349-117G8	8.78	0.59	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	15.33	1.51	0.95	0.66
Keratinocyte - oral, donor1	11251-116E9	20.21	1.93	4.09	1.25
Keratocytes, donor1	11527-119I6	8.94	2.06	5.16	0.34
Keratocytes, donor2	11607-120I5	17.58	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	8.69	1.78	3.95	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	3.24	5.39	1.08
Lens Epithelial Cells, donor2	11609-120I7	22.26	2.88	2.65	3.00
Lens Epithelial Cells, donor3	11690-122I7	9.79	0.71	3.94	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.08	2.96	2.96	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	2.23	2.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	9.92	3.62	2.83	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	1.61	3.23	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	2.21	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.33	4.10	2.26	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.51	2.05	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.38	1.26	1.52	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.74	2.53	3.24	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	1.19	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	2.52	2.52	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.63	3.70	2.59	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.32	2.44	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.83	3.82	4.29	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.24	3.02	3.16	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	2.77	2.16	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	1.56	2.81	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.25	3.11	2.56	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.89	2.63	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.37	2.05	2.64	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	3.24	3.98	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.82	1.45	3.88	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	1.35	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.17	3.33	2.27	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	2.07	3.11	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.17	2.30	2.72	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.77	3.46	1.65	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	2.06	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.16	3.76	2.07	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.69	3.39	2.01	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	3.88	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	2.98	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.42	3.35	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.55	1.48	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	1.73	2.96	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.97	3.99	2.34	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	0.96	3.54	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.09	2.13	3.96	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.28	2.80	3.08	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.47	2.13	2.84	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	1.94	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.96	2.65	4.20	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	3.22	3.58	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	2.94	4.25	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	3.06	4.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.64	2.60	3.09	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	2.31	3.59	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	1.79	2.09	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	46.80	1.53	7.67	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	2.23	2.97	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	0.85	8.46	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	29.54	1.41	9.14	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	0.00	7.47	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	2.58	5.67	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	2.38	7.14	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	33.93	2.71	9.73	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.98	1.16	5.82	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	30.61	3.15	7.65	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	34.14	3.93	10.03	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	1.54	7.19	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.05	1.41	7.41	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.98	0.67	8.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	2.55	8.66	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.09	1.87	3.47	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.85	1.89	4.72	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	31.29	1.84	11.66	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	1.63	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	30.61	2.50	6.04	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.30	0.84	5.89	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	2.06	3.09	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	28.16	2.03	5.52	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	21.52	1.49	4.78	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	2.21	6.09	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	25.80	2.83	7.42	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.60	0.00	5.53	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	1.15	10.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	35.31	3.45	6.91	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.17	0.57	9.06	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	43.48	2.46	9.03	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.18	3.16	6.33	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	26.57	1.44	6.46	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.13	0.75	7.47	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	32.70	1.86	7.06	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.84	0.86	8.61	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	0.00	4.28	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	33.98	1.67	9.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.17	2.41	4.83	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	32.71	1.42	6.40	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	38.84	1.03	8.94	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	0.54	7.51	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	42.42	2.69	9.43	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	32.60	1.11	10.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	4.65	8.14	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	1.06	7.40	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.81	2.00	8.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	5.81	8.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.86	2.30	11.50	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	34.53	3.45	2.47	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	1.88	3.76	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.70	2.01	9.55	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.15	1.80	7.21	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	6.88	5.16	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	33.85	3.12	8.02	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.37	1.56	6.26	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	1.32	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	43.07	1.56	7.78	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.82	3.06	10.50	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	1.12	7.27	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.10	1.77	8.39	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	2.31	8.49	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.75	0.51	10.13	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.20	1.92	2.88	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	1.19	8.35	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	1.22	10.33	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	2.08	6.92	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	31.92	3.80	8.36	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	0.52	11.88	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.79	1.81	7.26	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.25	2.22	7.29	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	5.33	8.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.88	1.15	8.62	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	30.85	2.57	6.69	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	1.41	7.78	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	2.27	10.78	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.04	0.83	9.15	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	1.57	14.09	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	26.72	2.09	7.93	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	29.27	3.25	10.22	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	1.34	9.37	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	2.14	11.23	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	33.14	1.62	14.55	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	1.84	12.85	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	25.78	3.56	5.33	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.07	1.71	9.12	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	0.77	4.60	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	3.83	13.13	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.84	1.78	14.70	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.67	3.64	14.30	2.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	27.19	4.64	15.25	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	2.08	8.31	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.27	23.02	2.51	0.46
Macrophage - monocyte derived, donor2	11313-117C8	27.53	6.79	1.65	0.37
Macrophage - monocyte derived, donor3	11389-118C3	36.44	12.85	1.84	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	0.00	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	18.06	1.58	1.90	1.58
Mallassez-derived cells, donor3	11930-125I4	13.48	2.08	1.11	0.69
Mammary Epithelial Cell, donor1	11273-116H4	7.97	1.49	2.49	0.80
Mammary Epithelial Cell, donor2	11350-117G9	6.95	0.29	2.61	0.58
Mammary Epithelial Cell, donor3	11422-118F9	12.97	1.00	0.75	1.00
Mast cell - stimulated, donor1	11487-119E2	26.44	6.10	2.71	0.68
Mast cell, donor1	11563-120D6	40.55	10.27	1.62	1.41
Mast cell, donor2	11565-120D8	41.60	9.51	3.86	0.59
Mast cell, donor3	11566-120D9	50.65	10.13	4.28	0.68
Mast cell, donor4	11567-120E1	48.58	10.28	3.19	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	34.71	5.10	4.55	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	20.43	2.33	3.50	0.58
Mast cell, expanded, donor5	11939-126A4	38.43	10.32	3.33	1.84
Mast cell, expanded, donor8	11941-126A6	35.15	9.54	2.51	1.00
Melanocyte - dark, donor1	11502-119F8	18.51	4.68	2.59	0.50
Melanocyte - dark, donor2	11582-120F7	17.65	1.38	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	35.35	4.93	0.58	1.16
Melanocyte - light, donor1	11274-116H5	22.10	4.94	0.94	1.18
Melanocyte - light, donor2	11351-117H1	24.57	2.73	0.68	1.36
Melanocyte - light, donor3	11423-118G1	18.21	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	30.61	4.37	1.67	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	32.00	5.38	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	27.32	5.62	1.07	1.07
Meningeal Cells, donor1	11493-119E8	20.35	3.60	2.85	2.98
Meningeal Cells, donor2	11573-120E7	20.25	0.88	5.72	2.20
Meningeal Cells, donor3	11654-122E7	13.12	1.55	3.67	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.69	1.71	3.71	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	12.58	1.61	2.52	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	2.63	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	1.31	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.09	4.31	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.25	1.69	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	1.01	2.01	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.82	2.20	3.52	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	5.11	7.31	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	14.73	0.82	4.50	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.83	1.52	4.57	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.56	0.37	3.72	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	9.74	1.58	1.84	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	2.08	3.26	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	2.34	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	4.48	1.92	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	2.13	2.84	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.82	0.94	3.13	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.95	3.63	5.08	0.73
Mesothelial Cells, donor1	11247-116E5	26.25	1.59	2.39	1.59
Mesothelial Cells, donor2	12156-128G5	13.01	3.50	2.50	3.00
Mesothelial Cells, donor3	11402-118D7	16.84	1.52	2.31	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	8.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	37.43	10.34	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.20	5.59	1.18	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.06	8.06	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	5.39	1.66	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	6.95	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.78	9.51	2.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.62	6.98	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	26.62	6.91	1.42	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	16.23	7.13	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	7.08	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.76	4.94	3.04	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.07	7.64	1.27	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	19.67	5.37	0.89	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	5.03	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	6.77	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.74	3.57	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	3.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.20	4.60	1.15	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	16.20	4.42	1.05	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.45	4.69	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.88	5.58	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.78	2.67	1.11	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.46	5.26	1.10	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	2.53	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.22	4.89	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	3.23	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	3.84	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	0.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	2.74	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	5.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.33	2.63	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.16	4.46	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.70	3.42	1.37	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.44	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	1.78	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.27	2.24	1.68	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.55	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.97	2.41	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	0.83	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	2.77	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.64	2.28	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.57	2.07	1.66	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.03	1.81	1.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.02	3.43	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	2.54	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.21	2.94	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.43	7.78	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.09	2.54	0.99	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.42	3.82	1.59	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	22.11	1.77	1.77	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	2.28	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.92	1.70	0.57	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.06	4.42	1.72	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	21.51	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.82	3.53	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.68	4.04	4.04	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.26	5.36	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.78	5.66	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	19.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	43.37	20.70	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	47.34	21.04	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	45.86	17.59	0.79	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	51.22	16.76	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	47.32	12.77	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	38.89	17.58	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.50	8.82	1.02	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	32.42	22.10	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	34.44	17.95	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	6.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.33	13.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	11.59	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	39.39	22.22	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.98	7.59	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	5.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.91	7.29	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	9.06	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.13	1.51	4.52	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	1.57	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	0.00	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.61	1.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	1.52	3.23	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	3.19	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	1.67	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	1.86	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.70	1.89	2.16	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.30	2.10	1.68	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	1.49	2.98	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.45	3.25	0.54	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.65	2.04	1.13	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.31	1.47	1.80	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	15.86	1.64	1.64	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	0.53	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	1.80	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.50	1.64	1.97	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.59	0.49	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.23	3.00	2.29	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	1.38	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	0.96	3.53	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.59	1.38	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.71	1.56	1.34	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.43	1.69	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	2.37	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	2.15	4.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.00	2.33	2.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.33	0.90	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	0.40	3.17	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	1.86	1.86	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.22	0.76	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.12	2.28	1.63	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.59	0.87	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	0.90	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	0.88	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	1.33	3.32	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.37	2.48	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.19	1.15	1.53	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	18.75	2.12	6.65	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.16	1.11	2.21	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	1.36	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.55	0.63	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.50	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	0.79	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	13.79	1.12	2.86	0.75
Myoblast, donor2	11322-117D8	13.62	1.34	2.11	0.77
Myoblast, donor3	11398-118D3	20.35	1.85	2.19	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	27.14	5.69	1.02	0.88
Natural Killer Cells, donor1	11230-116C6	55.97	8.61	2.46	0.31
Natural Killer Cells, donor2	11311-117C6	45.23	7.24	4.82	0.60
Natural Killer Cells, donor3	11387-118C1	59.63	10.31	1.84	0.37
Neural stem cells, donor1	11275-116H6	18.15	3.63	1.09	0.73
Neural stem cells, donor2	11352-117H2	11.55	3.85	9.63	1.93
Neurons, donor1	11494-119E9	15.93	3.41	20.48	4.55
Neurons, donor2	11574-120E8	11.89	0.66	15.41	2.20
Neurons, donor3	11655-122E8	10.69	3.29	9.87	2.47
Neutrophils, donor1	11233-116C9	101.15	104.86	12.06	0.00
Neutrophils, donor2	11314-117C9	78.27	92.76	5.80	0.00
Neutrophils, donor3	11390-118C4	65.97	87.35	13.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	9.74	1.31	2.97	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	12.37	1.30	3.26	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	10.43	0.80	4.61	1.00
Olfactory epithelial cells, donor1	11933-125I7	10.05	1.38	1.10	0.96
Olfactory epithelial cells, donor2	11934-125I8	11.29	1.45	1.01	0.87
Olfactory epithelial cells, donor3	11935-125I9	10.90	0.57	1.59	0.45
Olfactory epithelial cells, donor4	11936-126A1	9.45	1.46	2.73	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	2.41	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.72	1.91	6.17	0.64
Osteoblast - differentiated, donor2	11353-117H3	25.15	0.00	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	3.72	1.86	0.00
Osteoblast, donor1	11277-116H8	20.52	4.10	3.91	1.37
Osteoblast, donor2	11354-117H4	9.83	4.21	2.81	2.11
Osteoblast, donor3	11426-118G4	17.24	1.78	3.02	1.07
Pancreatic stromal cells, donor1	11249-116E7	13.06	2.19	2.86	0.51
Pericytes, donor1	11491-119E6	23.37	4.78	7.57	1.89
Pericytes, donor2	11571-120E5	19.47	4.30	5.43	2.26
Pericytes, donor3	11652-122E5	16.68	2.03	3.66	1.42
Perineurial Cells, donor1	11499-119F5	14.24	1.92	4.52	2.03
Perineurial Cells, donor2	11579-120F4	24.84	2.94	1.10	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	52.27	30.60	2.87	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	53.62	24.98	2.94	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.21	25.75	2.20	0.26
Placental Epithelial Cells, donor1	11278-116H9	27.03	3.59	4.78	0.72
Placental Epithelial Cells, donor2	11355-117H5	15.52	2.22	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.15	1.57	4.12	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.99	2.85	2.53	0.95
Preadipocyte - breast, donor1	11467-119B9	11.44	1.13	2.81	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.57	0.78	3.65	0.91
Preadipocyte - breast, donor2	11328-117E5	18.46	2.48	2.93	0.68
Preadipocyte - omental, donor1	11468-119C1	18.33	3.41	4.37	0.43
Preadipocyte - omental, donor2	11329-117E6	13.97	3.93	4.80	0.00
Preadipocyte - omental, donor3	11403-118D8	16.33	1.72	2.72	0.14
Preadipocyte - perirenal, donor1	11469-119C2	20.67	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.14	2.15	1.54	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	14.34	1.95	1.95	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	19.24	2.38	2.38	0.85
Preadipocyte - visceral, donor1	11280-116I2	13.04	1.21	2.05	0.37
Preadipocyte - visceral, donor2	11357-117H7	7.82	0.92	4.14	1.38
Preadipocyte - visceral, donor3	11429-118G7	12.23	0.94	1.99	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.27	1.51	3.32	1.81
Prostate Epithelial Cells, donor2	11331-117E8	9.21	1.08	2.17	0.14
Prostate Epithelial Cells, donor3	11404-118D9	4.41	1.10	2.63	0.18
Prostate Stromal Cells, donor1	11254-116F3	13.90	1.03	1.94	1.25
Prostate Stromal Cells, donor2	11332-117E9	8.79	1.43	2.15	1.43
Prostate Stromal Cells, donor3	11405-118E1	10.74	1.36	1.88	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	38.32	2.19	5.47	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.64	1.04	4.02	1.18
Renal Epithelial Cells, donor1	11517-119H5	36.52	5.58	5.07	3.04
Renal Epithelial Cells, donor2	11597-120H4	29.88	4.27	0.71	4.98
Renal Epithelial Cells, donor3	11678-122H4	11.65	1.48	6.14	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	5.45	2.72	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.98	5.12	2.29	1.48
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.54	2.22	1.78	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	6.65	5.99	0.67
Renal Mesangial Cells, donor1	11518-119H6	24.65	2.86	4.62	1.76
Renal Mesangial Cells, donor2	11598-120H5	30.72	1.88	4.39	3.76
Renal Mesangial Cells, donor3	11679-122H5	31.07	3.33	4.44	3.88
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.28	2.42	2.42	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.13	0.84	2.11	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.42	1.35	3.47	2.51
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.96	2.85	4.15	3.63
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.17	0.85	4.55	3.13
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	0.00	3.09	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.28	1.25	5.77	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	27.66	5.88	7.48	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	46.46	0.89	2.68	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	2.75	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.78	1.74	1.16	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	30.95	4.29	3.64	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	35.35	4.17	3.67	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	46.62	4.02	4.35	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	49.37	3.35	5.33	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	36.60	3.61	4.20	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	38.83	4.39	3.00	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.01	2.05	2.74	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.77	3.63	2.87	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.76	4.12	3.58	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	43.61	2.87	4.73	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	36.27	3.22	2.15	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	52.44	4.65	6.42	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.87	2.68	2.87	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	36.71	3.82	2.52	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.19	2.82	5.45	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	35.83	3.72	2.39	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.18	3.60	2.14	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.36	2.10	6.11	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	32.25	2.99	2.78	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	31.11	3.08	3.08	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.96	4.27	3.25	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	32.09	1.64	3.10	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	34.21	3.43	2.70	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	49.03	4.43	5.51	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.73	3.30	5.43	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	34.72	3.57	3.57	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	41.86	4.21	4.91	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	41.26	3.32	4.98	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.64	4.20	3.32	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	45.95	3.55	4.18	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	39.43	2.42	4.44	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.12	3.24	2.38	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.19	4.24	2.31	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.25	2.75	5.33	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	30.31	3.43	3.02	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	38.25	2.46	3.28	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.09	1.53	3.24	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.80	3.70	5.47	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	35.18	3.47	2.67	2.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.72	4.01	2.63	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	46.67	3.57	4.76	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	48.37	3.22	3.43	3.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	36.73	3.20	3.11	2.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	39.13	3.14	5.24	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	52.28	4.53	3.93	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	44.30	3.18	3.55	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	43.67	4.80	4.80	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	69.36	5.48	4.26	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.62	4.82	4.52	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.76	6.79	8.82	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	70.99	9.29	4.49	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	70.25	6.14	6.85	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.34	8.11	5.76	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	57.69	5.41	4.21	3.61
Schwann Cells, donor1	11498-119F4	28.40	5.64	4.14	3.57
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	19.06	1.75	2.41	2.63
Sebocyte, donor1	11220-116B5	12.05	2.19	1.10	0.00
Sebocyte, donor2	11301-117B5	8.73	0.46	1.38	0.46
Sebocyte, donor3	11378-118B1	10.10	1.65	2.06	0.41
Sertoli Cells, donor1	11255-116F4	21.54	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	8.47	2.82	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.80	1.85	6.60	0.88
Skeletal Muscle Cells, donor2	11358-117H8	21.69	2.89	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	27.59	1.67	2.51	2.51
Skeletal Muscle Cells, donor4	11451-119A2	12.25	1.10	1.73	2.04
Skeletal Muscle Cells, donor5	11455-119A6	13.97	1.19	2.38	1.19
Skeletal Muscle Cells, donor6	11459-119B1	12.93	1.69	1.23	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.27	2.02	2.65	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.98	1.85	2.71	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.64	3.08	3.37	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.63	1.10	3.03	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	2.17	4.34	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.65	2.89	3.16	1.38
Skin - palm, donor1	10286-104F7	10.74	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.51	0.86	1.30	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	11.45	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.44	1.43	0.52	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	5.98	1.11	1.53	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.83	1.41	0.70	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.72	1.06	1.69	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	8.47	0.97	2.32	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.55	1.54	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.68	2.89	14.45	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	1.18	1.76	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.47	2.87	1.77	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	3.94	1.97	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	3.86	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.04	1.73	4.26	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.52	2.88	3.55	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.11	2.05	1.54	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.67	2.28	3.58	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.01	2.36	2.36	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.38	1.28	1.42	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.32	1.46	3.25	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.92	1.22	1.83	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.39	1.77	3.03	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	3.34	2.38	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.36	1.47	2.21	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.62	0.65	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.90	1.47	3.04	1.26
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.68	1.55	2.32	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.66	1.49	0.90	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.48	4.44	4.44	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	12.88	1.41	4.63	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.86	1.51	3.12	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	2.50	1.14	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	4.83	0.60	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.22	1.59	3.44	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.19	1.46	2.26	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.03	1.63	2.50	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	14.21	2.28	3.55	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.19	3.17	6.03	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	20.25	3.75	2.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	3.88	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	2.33	6.05	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	1.01	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.34	1.25	1.88	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.14	0.88	2.36	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	12.41	1.08	2.33	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.94	1.40	2.34	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.79	2.30	2.88	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.10	3.57	2.29	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.47	3.01	1.69	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.23	1.82	3.49	1.68
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.82	0.92	4.69	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	3.33	8.10	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.97	2.45	2.20	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.84	1.77	2.65	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.21	1.76	1.76	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.55	2.33	1.94	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.73	0.79	1.32	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.84	1.49	5.58	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.91	0.00	2.52	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	0.57	1.70	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.21	1.58	2.76	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	1.02	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	1.20	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	6.69	0.42	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	14.21	2.75	2.75	0.00
Synoviocyte, donor1	11291-117A4	9.26	1.68	1.68	0.17
Synoviocyte, donor2	11368-117I9	21.79	2.68	1.01	0.00
Synoviocyte, donor3	11440-118H9	14.75	2.46	1.79	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	34.66	2.50	4.29	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	17.13	4.40	4.40	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	8.96	1.94	0.86	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	0.77	2.32	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	13.17	0.57	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.17	6.89	7.50	1.48
Urethra, donor2	10319-105A4	8.99	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.69	1.86	2.39	0.80
Urothelial Cells, donor2	11600-120H7	13.22	0.80	0.40	0.80
Urothelial Cells, donor3	11681-122H7	18.34	1.38	2.52	1.38
Urothelial cells, donor0	11216-116B1	17.16	1.34	3.34	2.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	47.16	65.84	8.01	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	61.47	60.04	5.72	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	59.55	50.65	6.85	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	47.86	38.22	5.17	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	40.67	9.30	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	63.52	62.47	10.41	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	54.15	65.16	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	55.69	38.34	7.30	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.75	2.71	1.23	1.48
Wilms' tumor cell line:HFWT	10597-108E3	23.76	0.00	3.52	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.77	1.12	0.56	1.68
achilles tendon, donor2	10292-104G4	12.40	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.05	5.10	8.92	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	82.19	15.79	5.34	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	70.16	7.12	5.70	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	42.99	3.81	7.62	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	84.33	17.71	6.18	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	130.91	35.95	6.34	3.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.16	22.32	6.81	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	124.70	25.56	4.85	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	79.63	15.11	7.35	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	71.84	17.09	3.88	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	44.16	8.28	4.23	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	7.80	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	31.84	7.90	1.16	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	97.35	15.53	12.95	4.66
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	59.91	9.06	3.51	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	57.63	10.69	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.01	11.52	5.35	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	83.49	13.20	8.59	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	86.20	12.80	10.67	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	92.81	14.25	11.53	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	99.17	18.05	13.96	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	47.89	14.70	5.35	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.68	2.00	1.00	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.38	4.90	1.51	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.07	3.93	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	9.37	1.87	5.62
adenocarcinoma cell line:IM95m	10796-110I4	23.55	1.41	1.41	0.94
adipose tissue, adult, pool1	10010-101C1	12.25	3.88	3.57	0.31
adipose, donor1	10184-103D4	29.91	2.93	5.86	2.93
adipose, donor2	10185-103D5	17.44	1.62	3.24	3.65
adipose, donor3	10186-103D6	29.13	3.54	3.81	3.27
adipose, donor4	10187-103D7	34.67	0.87	3.47	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	21.78	1.58	2.68	5.21
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.41	3.07	4.54	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.80	2.14	3.22	1.43
amniotic membrane cells, donor1	12235-129G3	22.03	1.39	5.10	1.16
amniotic membrane cells, donor2	12236-129G4	42.94	4.73	3.04	1.35
amniotic membrane cells, donor3	12237-129G5	26.22	2.36	5.60	0.59
amygdala - adult, donor10196	10167-103B5	13.04	4.74	10.67	2.37
amygdala, adult, donor10252	10151-102I7	15.61	3.65	11.56	1.62
amygdala, newborn, donor10223	10360-105E9	7.42	1.94	7.42	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	13.24	4.07	11.08	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	27.58	3.75	5.29	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.75	2.00	6.01	3.67
aorta, adult, pool1	10052-101G7	17.65	4.51	6.08	0.20
appendix, adult	10189-103D9	24.45	9.31	6.21	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.85	1.38	5.85	0.69
artery, adult	10190-103E1	13.59	6.79	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	30.13	4.64	1.88	1.45
b cell line:RPMI1788	10427-106D4	29.59	3.87	2.38	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.54	1.66	3.33	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.09	1.29	1.89	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	6.19	0.00	2.18	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	64.87	14.54	1.68	1.12
bladder, adult, pool1	10011-101C2	10.86	2.72	4.02	0.33
blood, adult, pool1	10053-101G8	73.08	44.29	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	3.43	0.00	0.86
bone marrow, adult	10192-103E3	12.82	4.05	2.02	0.00
brain, adult, donor1	10084-102B3	16.40	7.18	9.23	0.00
brain, adult, pool1	10012-101C3	15.14	5.90	7.35	0.67
brain, fetal, pool1	10085-102B4	21.37	0.00	8.01	2.67
breast carcinoma cell line:MCF7	10482-107A5	33.70	2.64	4.96	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.85	1.50	5.62	1.50
breast, adult, donor1	10080-102A8	18.31	4.42	5.68	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.48	2.29	2.29	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.68	2.16	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.94	0.69	5.06	5.06
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.62	1.21	2.18	0.97
carcinoid cell line:NCI-H1770	10703-109H1	11.75	2.82	2.35	1.41
carcinoid cell line:NCI-H727	10735-110B6	20.45	2.52	1.75	1.64
carcinoid cell line:SK-PN-DW	10719-109I8	20.28	3.80	4.12	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.34	4.79	8.78	4.26
caudate nucleus - adult, donor10196	10177-103C6	13.82	2.30	8.06	2.30
caudate nucleus, adult, donor10252	10164-103B2	20.08	5.86	13.72	1.67
caudate nucleus, adult, donor10258	10379-105H1	6.88	4.58	9.17	2.29
caudate nucleus, newborn, donor10223	10354-105E3	8.42	1.46	9.89	1.10
cerebellum - adult, donor10196	10173-103C2	23.31	8.74	17.48	0.00
cerebellum, adult, donor10252	10166-103B4	19.86	3.63	13.45	3.84
cerebellum, adult, pool1	10083-102B2	12.42	4.14	5.86	2.41
cerebellum, newborn, donor10223	10357-105E6	8.30	3.32	7.47	3.32
cerebral meninges, adult	10188-103D8	16.14	3.28	4.03	2.02
cerebrospinal fluid, donor2	10294-104G6	6.58	2.92	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	20.13	4.60	7.62	4.46
cervical cancer cell line:ME-180	10553-107I4	8.62	1.16	2.32	1.33
cervix, adult, pool1	10013-101C4	15.64	4.51	9.34	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.29	4.60	3.07	2.37
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	32.31	2.98	5.22	3.36
choriocarcinoma cell line:SCH	10785-110H2	15.89	0.74	2.46	1.85
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	1.90	4.27	1.42
chorionic membrane cells, donor1	12238-129G6	38.75	3.13	4.84	2.56
chorionic membrane cells, donor2	12239-129G7	24.76	2.49	2.98	0.80
chorionic membrane cells, donor3	12240-129G8	34.62	2.20	3.30	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	43.42	3.03	2.02	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	56.48	13.06	2.69	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	44.77	8.03	0.63	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.12	0.77	0.77	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.13	1.21	0.73	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	13.64	0.81	1.43	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	41.52	1.18	2.06	5.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	42.48	6.26	1.82	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.43	2.97	2.06	4.34
clear cell carcinoma cell line:TEN	10636-108I6	13.19	1.04	4.34	2.08
colon carcinoma cell line:CACO-2	10513-107D9	37.16	1.28	2.38	1.83
colon carcinoma cell line:COLO-320	10420-106C6	26.61	5.32	3.04	1.90
colon, adult, donor1	10082-102B1	26.18	0.00	7.14	0.00
colon, adult, pool1	10014-101C5	18.10	4.23	3.64	1.29
colon, fetal, donor1	10070-101I7	26.57	0.62	6.80	0.62
common myeloid progenitor CMP, donor1	12130-128D6	178.76	36.67	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	14.87	1.70	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	17.51	1.66	1.81	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	22.84	1.41	1.27	0.99
corpus callosum, adult, pool1	10042-101F6	37.59	9.18	7.96	1.88
cruciate ligament, donor2	10295-104G7	10.54	6.48	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	12.84	4.82	1.61	0.80
diencephalon, adult	10193-103E4	17.28	4.32	4.80	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	18.83	2.76	1.38	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	11.03	2.05	2.56	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.89	1.20	3.13	2.65
ductus deferens, adult	10196-103E7	16.45	3.49	6.48	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	5.76	8.64	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	24.28	2.21	9.56	1.47
dura mater, adult, donor1	10041-101F5	29.40	11.07	2.40	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.98	2.00	8.66	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.79	1.58	6.45	3.01
embryonic pancreas cell line:1B2C6	10604-108F1	13.57	0.62	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	10.90	0.61	1.21	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.72	0.31	0.93	2.16
embryonic pancreas cell line:2C6	10603-108E9	18.39	0.00	1.31	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	18.44	3.02	4.36	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.55	2.72	9.61	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.33	0.80	2.25	1.29
epidermoid carcinoma cell line:A431	10426-106D3	31.35	4.11	4.00	1.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	28.93	2.31	4.40	2.75
epididymis, adult	10197-103E8	17.16	3.77	2.93	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.21	5.32	2.66	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.45	1.57	0.00	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	23.72	2.36	2.62	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.59	2.17	2.56	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.01	3.81	2.91	2.02
esophagus, adult, pool1	10015-101C6	10.83	2.23	4.99	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.16	2.25	9.77	1.88
eye - muscle inferior rectus, donor1	10272-104E2	16.90	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	5.73	8.03	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	16.03	11.66	2.91	1.46
eye, fetal, donor1	10054-101G9	13.47	2.03	12.46	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	24.62	2.44	1.15	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.56	3.09	2.85	3.56
frontal lobe, adult, pool1	10040-101F4	19.05	6.00	10.41	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	35.13	2.10	2.40	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	35.57	2.29	8.69	6.40
gall bladder, adult	10198-103E9	20.76	5.55	6.76	0.24
gamma delta positive T cells, donor1	11937-126A2	66.03	10.74	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	66.48	16.81	2.24	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.07	2.32	1.69	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.44	1.16	5.42	4.64
gastric cancer cell line:AZ521	10549-107H9	21.15	0.98	2.95	2.79
gastric cancer cell line:GSS	10560-108A2	16.47	0.92	6.41	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	18.51	1.83	7.31	2.74
giant cell carcinoma cell line:LU65	10487-107B1	4.36	0.23	1.72	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	28.27	3.36	5.88	2.52
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.22	1.75	2.24	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.14	1.90	2.01	2.22
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.73	1.40	2.53	1.69
glioblastoma cell line:T98G	10485-107A8	15.67	2.43	1.55	0.88
glioma cell line:GI-1	10413-106B8	47.74	5.27	1.76	3.22
globus pallidus - adult, donor10196	10175-103C4	18.95	1.46	3.64	0.73
globus pallidus, adult, donor10252	10161-103A8	32.46	10.01	10.01	1.22
globus pallidus, adult, donor10258	10367-105F7	13.69	6.85	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	8.53	2.13	8.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	283.87	58.73	2.45	12.24
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	141.12	31.36	15.68	5.23
granulosa cell tumor cell line:KGN	10624-108H3	8.96	1.60	1.92	0.96
hIPS +CCl2, biol_rep1	14383-156B9	22.96	3.21	1.38	1.38
hIPS +CCl2, biol_rep2	14384-156C1	16.92	0.91	3.66	6.86
hIPS +CCl2, biol_rep3	14385-156C2	21.26	0.64	2.58	2.58
hIPS, biol_rep1	14380-156B6	25.87	1.44	4.31	2.87
hIPS, biol_rep2	14381-156B7	19.20	0.00	1.37	4.80
hIPS, biol_rep3	14382-156B8	16.55	3.31	5.52	3.31
hairy cell leukemia cell line:Mo	10712-109I1	18.96	0.86	2.59	1.72
heart - mitral valve, adult	10205-103F7	10.76	2.39	3.89	0.30
heart - pulmonic valve, adult	10206-103F8	10.46	2.09	3.92	0.52
heart - tricuspid valve, adult	10207-103F9	18.32	1.67	7.49	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	12.04	0.82	2.86	0.41
heart, adult, diseased, donor1	10051-101G6	15.33	1.28	5.54	0.00
heart, adult, pool1	10016-101C7	10.35	2.53	4.37	1.15
heart, fetal, pool1	10046-101G1	14.27	2.77	9.65	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	1.54	2.78	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	5.95	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	35.58	3.20	3.09	3.20
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.70	3.64	3.40	2.79
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	42.24	3.54	4.55	3.23
hepatoma cell line:Li-7	10484-107A7	19.35	1.56	1.11	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	40.30	4.12	4.42	3.22
hippocampus - adult, donor10196	10169-103B7	11.36	3.79	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	17.96	7.76	11.02	1.63
hippocampus, adult, donor10258	10374-105G5	8.96	0.50	7.47	1.00
hippocampus, newborn, donor10223	10363-105F3	7.75	0.35	7.75	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	43.33	3.05	14.65	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.29	3.73	9.23	6.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	29.71	3.55	12.69	7.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	20.30	2.82	5.64	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	31.50	2.84	8.00	6.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.92	5.31	15.18	6.83
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	25.69	4.38	4.09	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.22	5.39	6.46	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.85	3.75	5.42	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.91	3.79	3.55	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.02	3.38	4.66	4.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	3.37	4.71	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.91	1.56	6.89	5.01
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	1.97	10.32	5.90
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	26.18	2.62	11.35	12.22
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.70	3.44	7.06	5.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.89	4.80	6.54	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	22.49	4.00	8.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.42	5.09	6.78	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	4.09	5.00	6.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	22.24	3.76	3.76	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	29.72	4.25	4.08	5.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	34.26	3.48	3.48	4.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.01	3.29	3.89	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.90	1.29	9.61	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.38	3.14	7.13	6.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	30.22	0.82	9.80	7.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	33.10	3.17	7.04	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.02	3.48	5.38	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.54	4.84	5.45	4.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.44	5.17	5.17	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.88	2.66	3.32	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	29.24	3.08	6.41	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.72	3.83	4.60	4.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	34.08	3.79	3.03	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.16	2.35	2.35	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	32.60	2.66	9.42	5.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	30.30	1.78	10.70	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	1.95	6.34	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.15	1.53	6.11	7.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	61.81	6.51	0.00	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	32.76	3.64	9.60	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.76	2.74	7.11	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.25	2.90	6.15	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.06	1.42	3.20	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	2.39	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	34.26	4.47	4.33	5.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.97	2.42	2.96	2.69
immature langerhans cells, donor1	11904-125F5	27.36	8.72	0.24	0.48
immature langerhans cells, donor2	11905-125F6	33.27	25.35	1.58	0.00
insula, adult, pool1	10039-101F3	19.49	5.02	13.91	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	28.61	2.93	1.95	0.65
kidney, adult, pool1	10017-101C8	17.62	3.10	3.30	0.40
kidney, fetal, pool1	10045-101F9	18.39	4.39	12.87	2.05
large cell lung carcinoma cell line:IA-LM	10509-107D5	53.97	5.68	4.83	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.64	0.69	4.84	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.86	1.83	1.83	1.28
left atrium, adult, donor1	10079-102A7	12.53	3.81	0.00	0.00
left ventricle, adult, donor1	10078-102A6	9.10	1.01	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	14.23	0.55	1.37	3.28
leiomyoma cell line:10964C	10569-108B2	11.50	1.08	5.03	1.44
leiomyoma cell line:15242A	10570-108B3	12.50	2.17	2.17	0.54
leiomyoma cell line:15425	10571-108B4	12.14	1.46	2.91	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	48.10	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	27.15	5.90	2.01	0.94
liposarcoma cell line:KMLS-1	10782-110G8	20.93	2.19	2.34	1.41
liposarcoma cell line:SW 872	10726-110A6	25.59	4.26	1.83	2.56
liver, adult, pool1	10018-101C9	29.98	3.73	2.11	2.59
liver, fetal, pool1	10086-102B5	22.58	3.76	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	11.23	2.33	3.50	0.58
locus coeruleus, adult, donor10252	10165-103B3	20.67	5.72	7.57	1.11
locus coeruleus, adult, donor10258	10375-105G6	22.85	7.62	3.39	1.13
locus coeruleus, newborn, donor10223	10362-105F2	7.15	3.79	7.99	0.84
lung adenocarcinoma cell line:A549	10499-107C4	17.58	0.69	0.69	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	27.58	0.69	3.45	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.31	1.58	0.79	0.92
lung, adult, pool1	10019-101D1	21.85	6.14	3.54	0.35
lung, fetal, donor1	10068-101I5	13.41	4.85	15.13	0.57
lung, right lower lobe, adult, donor1	10075-102A3	23.37	4.12	5.04	2.29
lymph node, adult, donor1	10077-102A5	32.19	11.36	2.84	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.04	4.38	4.82	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.81	2.41	3.32	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	3.40	4.25	1.70
mature adipocyte, donor1	12231-129F8	10.21	1.33	0.44	0.00
mature adipocyte, donor2	12232-129F9	5.81	1.45	0.62	0.42
mature adipocyte, donor3	12233-129G1	3.79	0.95	0.47	0.95
mature adipocyte, donor4	12234-129G2	5.79	0.26	2.37	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	14.53	1.43	1.67	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	1.13	9.02	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	15.26	5.89	9.56	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	9.53	3.18	4.45	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	11.09	0.85	13.22	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	10.80	1.69	11.31	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	12.52	5.09	12.31	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	0.00	7.71	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	2.15	14.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	10.38	3.24	2.60	2.60
medulla oblongata, adult, donor10252	10155-103A2	22.45	4.02	8.67	1.39
medulla oblongata, adult, pool1	10038-101F2	21.88	7.75	4.98	1.31
medulla oblongata, newborn, donor10223	10361-105F1	14.93	3.82	9.37	1.39
medulloblastoma cell line:D283 Med	10838-111E1	27.90	1.99	11.07	3.54
medulloblastoma cell line:ONS-76	10759-110E3	26.17	2.93	0.98	2.57
melanoma cell line:COLO 679	10514-107E1	12.79	0.86	0.72	0.72
melanoma cell line:G-361	10465-106H6	16.56	1.90	1.09	1.90
meningioma cell line:HKBMM	10691-109F7	11.22	1.09	1.09	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	30.84	1.76	9.69	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	38.37	4.41	9.33	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.86	1.84	1.99	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.18	2.00	1.64	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.49	1.24	4.97	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.09	1.40	1.83	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	26.96	2.50	1.93	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	19.43	2.08	3.47	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.15	3.60	2.92	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.75	2.65	3.45	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.29	2.25	2.12	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.61	3.92	3.11	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.91	1.99	1.85	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.75	3.29	0.99	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.57	2.21	2.21	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.90	3.14	4.89	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	20.82	1.63	3.67	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	0.72	3.24	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.52	2.69	2.59	1.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.58	2.05	2.05	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.62	2.10	5.87	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.93	1.79	2.54	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.66	2.01	3.06	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.88	1.84	3.68	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.88	2.00	3.43	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	19.79	2.53	2.11	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.64	1.83	2.28	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.37	2.56	2.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	1.05	2.36	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.72	1.54	1.54	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.71	0.94	2.12	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.32	2.03	1.69	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.75	2.75	2.75	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.29	0.93	2.32	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.52	2.60	2.02	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.29	0.67	1.78	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.39	3.61	1.92	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	2.20	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.47	1.34	2.35	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	2.46	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.18	1.72	0.43	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	5.47	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.89	1.30	1.62	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	5.82	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	4.26	4.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	1.64	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	3.11	2.33	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	3.97	0.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	4.74	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	3.66	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	3.17	4.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.49	2.41	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.93	1.63	3.67	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	1.59	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	1.77	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.96	1.56	2.49	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	1.18	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	2.07	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	0.99	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.18	1.27	1.27	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	0.40	2.42	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	1.82	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	1.39	1.79	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.41	1.30	1.62	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	3.06	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	3.09	1.55	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	3.31	1.18	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	18.53	2.32	2.78	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.46	2.16	2.36	0.51
mesothelioma cell line:Mero-25	10850-111F4	18.16	3.63	1.82	1.36
mesothelioma cell line:Mero-41	10851-111F5	14.42	1.71	1.71	1.96
mesothelioma cell line:Mero-48a	10852-111F6	12.84	1.77	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	12.61	2.37	2.37	0.79
mesothelioma cell line:Mero-83	10854-111F8	17.36	1.87	2.21	2.04
mesothelioma cell line:Mero-84	10855-111F9	18.96	3.54	2.53	1.52
mesothelioma cell line:Mero-95	10856-111G1	12.84	1.66	1.24	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	10.77	0.50	0.99	0.66
mesothelioma cell line:NCI-H226	10846-111E9	11.04	1.45	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	29.89	3.25	2.39	3.07
mesothelioma cell line:NCI-H28	10845-111E8	30.79	2.04	2.04	3.31
mesothelioma cell line:No36	10857-111G2	10.44	0.98	3.91	1.30
mesothelioma cell line:ONE58	10858-111G3	13.01	1.63	1.63	1.63
migratory langerhans cells, donor1	11901-125F2	14.97	1.34	4.99	0.58
migratory langerhans cells, donor2	11902-125F3	14.29	1.95	4.27	0.73
migratory langerhans cells, donor3	11903-125F4	14.54	3.77	4.49	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	27.42	2.94	3.26	5.55
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.59	0.64	1.06	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.51	1.38	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.56	1.33	1.71	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	67.08	12.57	10.16	2.96
myeloma cell line:PCM6	10474-106I6	32.22	6.92	2.17	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	35.00	4.57	0.51	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.59	3.14	2.75	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.36	0.78	4.90	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.65	1.03	4.56	0.44
nasal epithelial cells, donor2	12227-129F4	16.01	4.42	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	35.43	3.68	10.58	3.91
neuroblastoma cell line:NB-1	10539-107G8	48.27	5.24	8.42	3.55
neuroblastoma cell line:NBsusSR	10607-108F4	23.20	1.90	7.38	6.12
neuroblastoma cell line:NH-12	10555-107I6	29.44	5.59	9.32	7.45
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.76	1.66	10.68	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.68	1.43	9.98	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	47.09	7.04	7.04	4.03
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.71	3.18	3.18	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	13.84	2.13	1.60	0.27
neutrophil PMN, donor1	12133-128D9	119.00	74.37	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	39.84	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	9.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	48.20	10.65	0.68	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	2.40	4.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	19.88	1.28	5.45	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.82	2.10	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	16.03	5.53	13.12	1.78
occipital cortex - adult, donor10196	10172-103C1	12.36	2.06	10.30	0.00
occipital cortex, adult, donor10252	10163-103B1	23.08	5.10	13.95	1.61
occipital cortex, newborn, donor10223	10355-105E4	5.46	1.46	17.83	0.00
occipital lobe, adult, donor1	10076-102A4	14.43	5.77	7.35	1.57
occipital lobe, fetal, donor1	10073-102A1	10.73	2.15	33.04	0.86
occipital pole, adult, pool1	10036-101E9	17.74	4.97	12.46	2.60
olfactory region, adult	10195-103E6	17.00	4.01	6.69	0.96
optic nerve, donor1	10277-104E7	14.01	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.70	2.28	2.28	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	39.84	2.47	6.46	4.81
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4.40	0.17	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	11.20	1.04	0.92	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	13.52	0.59	1.47	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	37.37	6.54	1.87	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	122.57	11.88	4.88	6.36
ovary, adult, pool1	10020-101D2	17.12	4.80	10.57	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	36.11	3.67	1.10	2.38
pancreas, adult, donor1	10049-101G4	86.54	5.64	8.47	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	28.23	0.28	3.07	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	27.43	4.94	5.11	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	10.93	0.83	4.80	1.16
paracentral gyrus, adult, pool1	10035-101E8	14.74	5.49	11.62	2.01
parietal cortex, adult, donor10258	10373-105G4	8.81	2.20	9.54	3.67
parietal lobe - adult, donor10196	10171-103B9	12.23	4.70	6.58	1.88
parietal lobe, adult, donor10252	10157-103A4	13.40	3.42	12.83	2.00
parietal lobe, adult, pool1	10034-101E7	18.24	6.34	10.40	2.03
parietal lobe, fetal, donor1	10072-101I9	12.61	2.91	19.40	1.94
parietal lobe, newborn, donor10223	10356-105E5	7.10	1.50	15.33	0.00
parotid gland, adult	10199-103F1	14.18	2.47	4.32	1.23
penis, adult	10200-103F2	13.96	3.22	3.76	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.69	1.67	6.51	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.14	1.75	6.41	2.48
pineal gland - adult, donor10196	10179-103C8	8.39	1.94	3.87	0.65
pineal gland, adult, donor10252	10160-103A7	13.03	4.74	13.62	2.37
pineal gland, adult, donor10258	10377-105G8	10.66	1.25	7.52	0.63
pituitary gland - adult, donor10196	10180-103C9	19.22	1.01	12.14	1.01
pituitary gland, adult, donor10252	10162-103A9	26.06	2.61	32.31	2.61
pituitary gland, adult, donor10258	10378-105G9	17.88	3.40	13.62	0.00
placenta, adult, pool1	10021-101D3	13.55	4.95	4.09	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	35.23	5.43	1.46	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.75	2.65	5.29	4.20
pons, adult, pool1	10033-101E6	15.49	6.11	6.37	2.24
postcentral gyrus, adult, pool1	10032-101E5	19.18	7.50	12.64	2.88
promyelocytes/myelocytes PMC, donor1	12132-128D8	148.49	41.83	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	11.02	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	23.47	11.74	11.74
prostate cancer cell line:DU145	10490-107B4	25.20	2.62	2.04	1.75
prostate cancer cell line:PC-3	10439-106E7	17.06	3.27	3.27	1.63
prostate, adult, pool1	10022-101D4	16.42	5.26	11.43	1.09
putamen, adult, donor10196	10176-103C5	16.52	2.83	10.62	2.83
putamen, adult, donor10252	10152-102I8	19.61	5.88	7.84	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	2.19	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	12.81	2.90	6.52	1.45
putamen, newborn, donor10223	10365-105F5	5.25	1.50	11.99	0.00
rectal cancer cell line:TT1TKB	10469-106I1	28.51	1.75	1.45	2.04
rectum, fetal, donor1	10067-101I4	25.04	8.35	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.69	0.85	2.76	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.17	0.83	12.01	0.83
retina, adult, pool1	10030-101E3	22.46	6.36	11.03	2.78
retinoblastoma cell line:Y79	10475-106I7	50.14	4.68	9.09	5.98
rhabdomyosarcoma cell line:KYM-1	10787-110H4	20.16	2.46	1.48	3.07
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	36.56	3.09	4.22	3.37
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.82	1.52	0.76	0.76
salivary acinar cells, donor1	11771-123I7	8.58	0.97	2.27	0.32
salivary acinar cells, donor2	11772-123I8	7.85	1.24	1.38	0.41
salivary acinar cells, donor3	11773-123I9	14.57	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	10.87	2.29	6.29	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.71	2.36	1.60	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.39	2.59	1.18	0.59
seminal vesicle, adult	10201-103F3	14.81	3.17	4.23	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.49	0.24	2.67	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.13	2.01	5.54	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	23.08	1.00	4.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.66	2.55	8.73	2.55
signet ring carcinoma cell line:Kato III	10436-106E4	20.34	2.10	1.66	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	12.26	0.90	0.52	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	0.71	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	7.80	1.68	1.80	0.48
skeletal muscle, fetal, donor1	10066-101I3	20.10	3.02	2.01	2.01
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	3.79	5.68	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	30.35	4.00	3.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	21.75	4.41	16.08	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	48.96	1.73	16.96	5.98
small cell lung carcinoma cell line:LK-2	10541-107H1	16.48	5.27	1.81	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	32.01	2.09	25.09	7.08
small cell lung carcinoma cell line:WA-hT	10562-108A4	57.09	6.54	3.70	5.67
small intestine, adult, pool1	10024-101D6	18.27	4.06	2.75	0.48
small intestine, fetal, donor1	10064-101I1	26.54	4.42	5.16	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	9.23	2.56	2.56
smooth muscle, adult, pool1	10048-101G3	13.96	2.33	4.14	0.26
somatostatinoma cell line:QGP-1	10781-110G7	30.55	4.02	1.34	1.34
spinal cord - adult, donor10196	10181-103D1	12.85	5.05	2.52	1.15
spinal cord, adult, donor10252	10159-103A6	31.15	9.46	6.31	0.79
spinal cord, adult, donor10258	10369-105F9	17.99	5.53	5.53	2.77
spinal cord, fetal, donor1	10056-101H2	30.49	9.76	9.76	1.83
spinal cord, newborn, donor10223	10359-105E8	23.88	4.13	7.35	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.43	1.19	2.09	1.94
spleen, adult, pool1	10025-101D7	37.12	14.76	3.96	0.55
spleen, fetal, pool1	10044-101F8	35.83	13.98	6.28	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.46	1.86	2.79	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.48	2.09	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	7.69	1.75	7.34	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.65	1.56	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.71	1.80	1.91	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	38.55	3.39	8.05	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	0.42	2.54	2.54
stomach, fetal, donor1	10062-101H8	13.88	6.41	1.07	0.00
submaxillary gland, adult	10202-103F4	19.94	1.71	4.56	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	33.03	10.80	9.76	1.25
substantia nigra, adult, donor10258	10371-105G2	15.52	3.10	4.66	2.07
substantia nigra, newborn, donor10223	10358-105E7	12.01	2.12	5.65	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	31.41	2.98	2.75	0.92
temporal lobe, adult, pool1	10031-101E4	19.07	6.27	12.04	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	16.38	2.85	32.76	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	15.38	3.08	30.77	0.88
tenocyte, donor1	11763-123H8	21.99	2.09	3.49	0.70
tenocyte, donor2	11765-123I1	27.47	2.67	0.76	0.00
tenocyte, donor3	11768-123I4	21.13	1.85	2.22	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	11.39	0.68	3.06	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	24.20	1.85	3.55	3.24
teratocarcinoma cell line:PA-1	10807-111A6	27.43	4.18	3.41	4.03
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.59	4.57	2.54	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.23	2.65	2.27	7.19
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	33.48	2.94	3.05	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.59	2.61	0.98	1.30
testis, adult, pool1	10026-101D8	27.38	10.52	6.66	0.64
testis, adult, pool2	10096-102C6	30.67	17.14	9.02	1.80
thalamus - adult, donor10196	10168-103B6	16.56	5.52	5.52	3.31
thalamus, adult, donor10252	10154-103A1	20.32	5.63	10.00	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.21	4.28	3.29	0.16
thalamus, newborn, donor10223	10366-105F6	5.18	0.58	4.03	0.58
throat, adult	10209-103G2	12.98	4.49	2.75	0.50
throat, fetal, donor1	10061-101H7	26.51	3.05	6.40	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	13.51	2.38	3.18	2.58
thymus, adult, pool1	10027-101D9	60.84	9.15	13.92	0.60
thymus, fetal, pool1	10043-101F7	68.16	8.94	10.70	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	17.28	2.93	3.46	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	30.59	5.03	2.79	1.82
thyroid, adult, pool1	10028-101E1	26.87	2.99	18.48	2.52
thyroid, fetal, donor1	10060-101H6	22.68	3.43	9.23	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	3.08	0.00	0.00
tongue, adult	10203-103F5	6.98	1.40	3.02	0.23
tongue, fetal, donor1	10059-101H5	13.40	3.55	4.34	1.58
tonsil, adult, pool1	10047-101G2	36.46	10.62	5.21	1.30
trachea, adult, pool1	10029-101E2	21.92	4.42	6.22	1.47
trachea, fetal, donor1	10058-101H4	22.31	3.46	6.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.59	1.42	2.13	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	21.68	2.63	2.33	1.62
transitional-cell carcinoma cell line:JMSU1	10492-107B6	49.83	3.45	1.25	4.07
tridermal teratoma cell line:HGRT	10694-109G1	19.03	9.51	1.90	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.31	2.20	3.05	1.19
umbilical cord, fetal, donor1	10057-101H3	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	15.19	4.95	12.29	1.37
uterus, fetal, donor1	10055-101H1	24.57	4.10	8.70	1.54
vagina, adult	10204-103F6	13.57	1.94	5.82	0.00
vein, adult	10191-103E2	37.48	10.52	4.38	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.78	4.27	1.60	1.60